Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Jun 2025 is 4.79% vs 23.25% in Jun 2024
Consolidate Net Profit
YoY Growth in quarter ended Jun 2025 is -2.68% vs 33.99% in Jun 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Jun 2025 is -7.01% vs 21.57% in Jun 2024
Interest
YoY Growth in quarter ended Jun 2025 is -12.77% vs 37.56% in Jun 2024
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Jun 2025 has fallen from Jun 2024
Compare Quarterly Results Of Sirio Pharma Co., Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Jun 2025 is 14.24% vs -17.90% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 4.79% vs 23.25% in Jun 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Jun 2025 is 41.24% vs -18.47% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -2.68% vs 33.99% in Jun 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Jun 2025 is 16.02% vs -10.96% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -7.01% vs 21.57% in Jun 2024
Quarterly - Interest
QoQ Growth in quarter ended Jun 2025 is 0.82% vs 360.38% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -12.77% vs 37.56% in Jun 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025
YoY Growth in quarter ended Jun 2025 has fallen from Jun 2024






